Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Filings indexed 450 across all filing types
Latest filing 2022-08-13 Regulatory Filings
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2022-08-13 English
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting to approve unaudited financial results for the quarter ended June 30, 2022. It references compliance with SEBI Listing Regulations and is dated August 6, 2022. The document does not contain any financial data or results itself, but only announces the meeting date for approval of the quarterly results. The length is only 1211 characters, indicating it is a brief announcement rather than a full report. According to the rules, such a notice is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain substantive financial data or the actual report.
2022-08-06 English
Appointment
Regulatory Filings
2022-08-03 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the status of securities dematerialization for the quarter ended June 30, 2022. It is a compliance certificate issued by Bigshare Services Pvt. Ltd. and does not contain financial statements, management discussion, or detailed report content. The document length is short (1731 characters) and primarily serves as a regulatory attestation or certification. Therefore, it fits the category of Regulatory Filings (RNS) rather than a full financial report or announcement.
2022-07-27 English
Resignation
Regulatory Filings
2022-07-19 English
Loss of share certificate
Major Shareholding Notification Classification · 90% confidence The document is extremely short (214 characters) and consists solely of a table listing shareholder names, folio numbers, share certificate numbers, and share counts. There is no narrative text, financial data, or regulatory references. This type of content typically corresponds to a Major Shareholding Notification or a similar disclosure of share ownership details. Given the presence of shareholder names and share counts, it aligns best with a Major Shareholding Notification (MRQ).
2022-07-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.